Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation
Which stocks are undervalued right now? Check free
Discover now →
Reliq Health Technologies Inc (RQHTF) fair value: what the stock is really worth
As of Jul 24, 2026: fair value of Reliq Health Technologies Inc $0.01, price $0.01, upside +0.0%, quality 37 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Fair value above price? Yes
- Good quality? No
- Add to watchlist
RH
Thin data
Sep 24, 2026
Thin data
Sep 24, 2026
Reliq Health Technologies Inc
RQHTF · USLow PriorityFair Value upside is limited and quality is weak.
·Fair value $0.0100 · Fairly valued (+0.0%)
!Quality 37/100
!Mixed Growth (revenue YoY +484.9 %/yr)
!Loss-making · -3.1% net margin (TTM)
!Low debt · negative free cash flow
!Narrow moat 14/100
!Evidence only low, so the estimate is less certain
Watch Reliq Health Technologies Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.
Watch for free
Pro now: $1 first month
What runs behind every stock
26
valuation models
8 families, DCF to NCAV
37
quality factors
margins, balance sheet, cashflow, debt
6
AI factors
moat, what no ratio measures
2,000+
data points
verified, per stock, median
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range $0.0001 – $1.00 · the $0.0100 price screens below the $0.0100 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Company profile
Reliq Health Technologies Inc., a healthcare technology company, develops secure telemedicine and virtual care solutions for the healthcare market. It provides iUGO Care platform, a software as a solution that allows complex patients to receive care in the home. The company was formerly known as Moseda Technologies Inc.
Show more
Reliq Health Technologies Inc., a healthcare technology company, develops secure telemedicine and virtual care solutions for the healthcare market. It provides iUGO Care platform, a software as a solution that allows complex patients to receive care in the home. The company was formerly known as Moseda Technologies Inc. and changed its name to Reliq Health Technologies Inc. in May 2016. Reliq Health Technologies Inc. was incorporated in 2005 is headquartered in Hamilton, Canada.
Stock analysis
Reliq Health Technologies Inc (RQHTF) currently trades at $0.0100, while our model-based Fair Value estimate is $0.0100, so the stock looks roughly fairly valued today (gap 0.0%).
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 88/100, which puts the evidence level at low.
Quality & growth
The Quality Score stands at 37/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Reliq Health Technologies Inc reported revenue of C$8.6M in FY2022 versus C$2.3M in FY2018, a compound +39.3%/yr. Reported net income was −C$8.2M in FY2022.
Key figures
Market cap $1.8M · P/S ratio 0.13 · EPS (TTM) $−0.1400 · Net margin −95.5% · Return on equity −4.5% · Return on assets (EBIT) −257% · Operating margin 12.9% · Revenue (TTM) C$14.6M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 22 out of 100 (low confidence).
What moves the price
For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at 0%, RQHTF screens richer than that median.
Fair Value models
Bear $0.0100
Fair Value $0.0100
Bull $0.0100
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.
Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.
Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham)
$0.0100
$0.0200
$0.0200
55
All 1 models by family
Asset-Based
NCAV (Graham)
$0.0100
$0.0200
$0.0200
55
Notify me when RQHTF reaches fair value
Put RQHTF on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Quality Score breakdown
Overall quality
37/100
Of which business quality 41 · Market factors (momentum, volatility) 25
Profitability
31
Margins and returns on capital today
Quality Growth
100
Are margins and returns improving?
Cashflow
33
Earnings quality: real cash, not paper profit
Fin. Strength
50
Balance sheet, leverage, solvency risk
Investment
33
Disciplined investing over empire-building
Low Volatility
84
Calm price path (market factor)
Momentum
0
Price trend over the last 3–12 months (market factor)
52W Momentum
2
Distance to the 52-week high (market factor)
Net Issuance
0
Share count: buybacks or dilution?
Revenue & earnings trend
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.
36/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+484.9%
Revenue growth 16 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+90.9%
’06
’12
’13
’14
’15
’16
’18
’20
’21
’22
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−1,533.9% (2017) → −97.0% (2022)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2022 is a loss year, no rate is defined from a loss
not computed
Watch RQHTF, get fair value alerts →
Compare Reliq Health Technologies Inc with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 129 stocks
Beats the industry median on 6/9 measures
Overall it ranks above its industry peers.
Valuation Multiplesvs Health Information Services median · lower = cheaper
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
None of the checked exposures detected
Similar stocks
10 more Health Information Services stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $278.57 | $306.43 | +10% |
| Pro Medicus Limited PME | A$161.00 | A$84.62 | −47% |
| BrightSpring Health Services, Inc BTSG | $56.54 | $25.86 | −54% |
| Hinge Health, Inc HNGE | $95.57 | $51.25 | −46% |
| HealthEquity, Inc HQY | $88.44 | $97.28 | +10% |
| Waystar Holding WAY | $24.70 | $27.17 | +10% |
| Doximity, Inc DOCS | $26.35 | $31.41 | +19% |
| XtalPi Holdings 2228 | HK$7.75 | HK$1.50 | −81% |
| Inventurus Knowledge Solutions Limited IKS | ₹1,779 | ₹1,883 | +6% |
| Privia Health Group PRVA | $19.62 | $5.02 | −74% |
Explore undervalued stocks
More undervalued Healthcare stocks →
All undervalued stocks
TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
🥇 Backtested Best
🏆 Big Names
⭐ Top Rated
💎 Quality on Sale
🚀 Profitable Growth
🧊 Quality Compounders
💵 Dividend Stars
📈 Strong Momentum
📉 Fallen Angels
⚖️ Deeply Undervalued
🔍 Small-Cap Gems
🏰 Moat at a Fair Price
💼 Insider Buying
🎩 Buffett-Style Quality
📚 Peter Lynch GARP
🧮 Greenblatt Magic Formula
🛡️ Graham Defensive
Discover tools
Stock screenerFilter by region, size and sector
Compare toolTwo stocks side by side
Extrinsic Value Calculator…Calculator with industry benchmark
Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
Frequently asked questions
Is Reliq Health Technologies Inc (RQHTF) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $0.0100 versus the last price from Jul 24, 2026 of $0.0100, about +0% upside (fairly valued).
What is the fair value of RQHTF?
Our model-based fair value for Reliq Health Technologies Inc is $0.0100 (as of Sep 24, 2026), built from audited fundamentals. Last price (from Jul 24, 2026): $0.0100.
What is the quality score of RQHTF?
Reliq Health Technologies Inc has a Quality Score of 37/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Reliq Health Technologies Inc (RQHTF)?
Our model-based price target is the fair value of $0.0100 (as of Sep 24, 2026) from 1 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Reliq Health Technologies Inc stock forecast for 2026?
Our models put fair value at $0.0100, about +0% upside versus the last price from Jul 24, 2026 of $0.0100 (fairly valued). The calculation is refreshed regularly with new filings.
What is the revenue of Reliq Health Technologies Inc (RQHTF)?
Reliq Health Technologies Inc reported trailing-twelve-month revenue of about C$14.6M (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of Reliq Health Technologies Inc (RQHTF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Reliq Health Technologies Inc it is $0.0100 per share (as of Sep 24, 2026), against a price of $0.0100. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Reliq Health Technologies Inc stock overvalued or undervalued in 2026?
As of Sep 24, 2026, RQHTF trades below its calculated fair value: price $0.0100, fair value $0.0100, a gap of about +0% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of RQHTF?
No. The price is what the market pays today ($0.0100); the fair value is what the company's own numbers justify ($0.0100). For Reliq Health Technologies Inc the two are $0.0000 per share apart. That gap is exactly why we show both numbers side by side.
How much is Reliq Health Technologies Inc worth?
The market values Reliq Health Technologies Inc at about $1.8M (market capitalisation, as of Sep 24, 2026). Per share that is $0.0100; our models calculate a fair value of $0.0100 per share.
How solid is the balance sheet of Reliq Health Technologies Inc (RQHTF)?
Balance-sheet figures for Reliq Health Technologies Inc (as of Sep 24, 2026): return on equity −4.5%, debt of 0.01 per unit of equity. They feed the Quality Score of 37/100, which measures business quality independently of the share price.
Which stocks are comparable to Reliq Health Technologies Inc?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Hinge Health, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Reliq Health Technologies Inc stock attractive at the current price?
The data as of Sep 24, 2026: price $0.0100, calculated fair value $0.0100 (+0%), Quality Score 37/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of RQHTF calculated?
We run Reliq Health Technologies Inc through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0100, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Reliq Health Technologies Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Reliq Health Technologies Inc (RQHTF)?
The latest price we hold is from Jul 24, 2026 and stands at $0.0100. Our model-based fair value is $0.0100, about +0% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Reliq Health Technologies Inc right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Reliq Health Technologies Inc
How large is the market capitalisation of Reliq Health Technologies Inc (RQHTF)?
The market capitalisation of Reliq Health Technologies Inc is $1.8M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Reliq Health Technologies Inc (RQHTF)?
The price-to-sales ratio of Reliq Health Technologies Inc is 0.13 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Reliq Health Technologies Inc (RQHTF)?
Earnings per share at Reliq Health Technologies Inc are $−0.1400. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Reliq Health Technologies Inc (RQHTF)?
The net margin of Reliq Health Technologies Inc is −95.5% (fiscal year 2022). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Reliq Health Technologies Inc (RQHTF)?
The return on equity (ROE) of Reliq Health Technologies Inc is −4.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Reliq Health Technologies Inc (RQHTF)?
On an EBIT basis the return on assets of Reliq Health Technologies Inc is −257% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Reliq Health Technologies Inc (RQHTF)?
The operating margin of Reliq Health Technologies Inc is 12.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Reliq Health Technologies Inc (RQHTF)?
Revenue at Reliq Health Technologies Inc is growing +88.5% versus a year earlier (3y avg +261%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Reliq Health Technologies Inc (RQHTF) generate?
The free cash flow of Reliq Health Technologies Inc is −C$8.0M (fiscal year 2022). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Reliq Health Technologies Inc (RQHTF) carry?
The net debt of Reliq Health Technologies Inc is C$172K (fiscal year 2022). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Reliq Health Technologies Inc in the live analysis
One click puts Reliq Health Technologies Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.